A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients

Chung-Wah Cheng, Hoi-Fung Mok, Cora W S Yau, Jasmine T M Chan, Yu-Chen Kang, Pui-Yan Lam, Linda L D Zhong, Chen Zhao, Bacon F L Ng, Annie O L Kwok, Doris M W Tse, Zhao-Xiang Bian, Chung-Wah Cheng, Hoi-Fung Mok, Cora W S Yau, Jasmine T M Chan, Yu-Chen Kang, Pui-Yan Lam, Linda L D Zhong, Chen Zhao, Bacon F L Ng, Annie O L Kwok, Doris M W Tse, Zhao-Xiang Bian

Abstract

Background: Constipation is a common problem among advanced cancer patients; however, many of them find limited effective from current therapies. Thus, we aimed to test the effect of a traditional Chinese herbal formula, modified MaZiRenWan (MZRW), by comparing with placebo among palliative cancer patients with constipation.

Methods: This is a randomized, double-blind, placebo-controlled trial. Participants aged over 18 were recruited and randomized to MZRW or placebo group in addition to current prescriptions (including ongoing laxatives treatment) for two weeks. Exclusion criteria included cognitive impairment, presence of a colostomy or gastrointestinal obstruction and estimated life expectancy of less than one month. Individualized modification of MZRW was allowed according to the traditional Chinese medicine (TCM) pattern of patient. The primary outcome was the global assessment of improvement, which reflected whether the constipation had improved, remained the same or worsened.

Results: Sixty patients, with mean age 75.2 years (range 47-95 years), were randomized to MZRW or placebo group. Among the MZRW group, 59.3% (16/27) had improvement in the global assessment score, as compared with 28.6% (8/28) of the placebo group (p-value = 0.022). Besides, the MZRW group had significant increase in stool frequency, and reduction in constipation severity and straining of defecation (p-value < 0.05). No serious adverse event was reported due to the research medication.

Conclusion: This pilot trial suggests modified MZRW is well-tolerated and effective for relief of constipation in patients with advance cancer. It could be considered as a potential treatment option for constipation in palliative care.

Trial registration: The trial had been registered in ClinicalTrials.gov with identifier number NCT02795390 [ https://ichgcp.net/clinical-trials-registry/NCT02795390 ] on June 10, 2016.

Keywords: Constipation; MaZiRenWan; Palliative care; Placebo; Randomized controlled trial; Traditional Chinese Medicine.

Conflict of interest statement

The authors declare that there is no conflict of interest.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Flow diagram

References

    1. Larkin PJ, Cherny NI, La Carpia D, et al. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(Suppl4):iv111–iv125. doi: 10.1093/annonc/mdy148.
    1. Wickham RJ. Managing constipation in adults with cancer. J Adv Pract Oncol. 2017;8(2):149–161.
    1. Bausewein C, Simon ST, Pralong A, et al. Palliative care of adult patients with cancer. Dtsch Arztebl Int. 2015;112(50):863–870.
    1. Laugsand EA, Jakobsen G, Kaasa S, Klepstad P. Inadequate symptom control in advanced cancer patients across Europe. Support Care Cancer. 2011;19(12):2005–2014. doi: 10.1007/s00520-010-1051-2.
    1. Cheng CW, Kwok AO, Bian ZX, Tse DM. A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practice. Support Care Cancer. 2012;21(1):149–156. doi: 10.1007/s00520-012-1504-x.
    1. Lu AP, Jia HW, Xiao C, Lu QP. Theory of traditional Chinese medicine and therapeutic method of diseases. World J Gastroenterol. 2004;10(13):1854–1856. doi: 10.3748/wjg.v10.i13.1854.
    1. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci. 2005;26(11):558–563. doi: 10.1016/j.tips.2005.09.006.
    1. Lin YJ, Chang HT, Lin MH, et al. Professionals’ experiences and attitudes toward use of traditional Chinese medicine in hospice palliative inpatient care units: a multicenter survey in Taiwan. Integr Med Res. 2021;10(2):100642. doi: 10.1016/j.imr.2020.100642.
    1. Cheng CW, Kwok AOL, Bian ZX, Tse DMW. The quintessence of traditional Chinese medicine: syndrome and its distribution among advanced cancer patients with constipation. Evid Based Complement Alternat Med. 2012;2012:739642.
    1. Cheng CW, Bian ZX, Zhu LX, Wu JCY, Sung JJY. Efficacy of a Chinese herbal proprietary medicine (hemp seed pill) for functional constipation. Am J Gastroenterol. 2011;106(1):120–129. doi: 10.1038/ajg.2010.305.
    1. Zhong LLD, Cheng CW, Kun W, et al. Efficacy of MaZiRenWan, a Chinese herbal medicine, in patients with functional constipation in a randomized controlled trial. Clin Gastroenterol Hepatol. 2019;17(7):1303–1310.e18. doi: 10.1016/j.cgh.2018.04.005.
    1. Bharucha AE, Lacy BE. Mechanisms, evaluation, and management of chronic constipation. Gastroenterology. 2020;158(5):1232–1249.e3. doi: 10.1053/j.gastro.2019.12.034.
    1. Chung VCH, Wu X, Hui EP, et al. Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses. Sci Rep. 2015;5:18111. doi: 10.1038/srep18111.
    1. Chung VCH, Wu X, Lu P, et al. Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis. Medicine (Baltimore) 2016;95(7):e2793. doi: 10.1097/MD.0000000000002793.
    1. Bensky D. Chinese herbal medicine: formulas & strategies. Washington: Eastland Press; 1990.
    1. Li X, Wei W. Chinese materia medica: combinations and applications. St. Albans: Donica; 2002.
    1. Cheng CW, Bian ZX, Wu TX. Systematic review of Chinese herbal medicine for functional constipation. World J Gastroenterol. 2009;15(39):4886–4895. doi: 10.3748/wjg.15.4886.
    1. Zhong LLD, Zheng G, Ge LD, et al. Chinese herbal medicine for constipation: zheng-based associations among herbs, formulae, proprietary medicines, and herb-drug interactions. Chin Med. 2016;11:28. doi: 10.1186/s13020-016-0099-4.
    1. Davies A, Leach C, Caponero R, et al. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer. 2020;28(1):23–33. doi: 10.1007/s00520-019-05016-4.
    1. Hanson B, Siddique SM, Scarlett Y, Sultan S, American Gastroenterological Association Institute Clinical Guidelines Committee American Gastroenterological Association Institute technical review on the medical management of opioid-induced constipation. Gastroenterology. 2019;156(1):229–253. doi: 10.1053/j.gastro.2018.08.018.
    1. Huang T, Ning ZW, Hu DD, et al. Uncovering American Gastroenterological Association Institute the mechanisms of Chinese herbal medicine (MaZiRenWan) for functional constipation by focused network pharmacology approach. Front Pharmacol. 2018;9:270. doi: 10.3389/fphar.2018.00270.
    1. Huang T, Zhao L, Lin CY, et al. Chinese herbal medicine (MaZiRenWan) improves bowel movement in function constipation through down-regulating oleamide. Front Pharmacol. 2020;10:1570. doi: 10.3389/fphar.2019.01570.
    1. Ferris FD, Bruera E, Cherny N, et al. Palliative cancer care a decade later: accomplishments, the need, next steps—from the American Society of Clinical Oncology. J Clin Oncol. 2009;27(18):3052–3058. doi: 10.1200/JCO.2008.20.1558.
    1. Lutz S. The history of hospice and palliative care. Curr Probl Cancer. 2011;35(6):304–309. doi: 10.1016/j.currproblcancer.2011.10.004.
    1. World Health Organization. Palliative care. 2020. . Accessed 23 Jan 2021.
    1. Zeng S, Liu Y, Wang X, et al. Traditional Chinese medicine could play an important role in integrative palliative care in China. J Altern Complement Med. 2020;26(9):770–773. doi: 10.1089/acm.2020.0160.
    1. Patwardhan B, Mutalik G. Search of novel model for integrative medicine. Chin J Integr Med. 2014;20(3):170–178. doi: 10.1007/s11655-014-1745-2.
    1. Cheng CW, Wu TX, Shang HC, et al. CONSORT Extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration. Ann Intern Med. 2017;167(2):112–121. doi: 10.7326/M16-2977.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다